Dr. Mark Frattini, MD

Dr. Mark Frattini, MD

Save
Medical Oncology  ·  
Male  ·  
53 y/o
(3)

Accepting new patients

Dr. Mark Frattini, MD is a medical oncology specialist in New York, NY and has been practicing for 16 years. He specializes in medical oncology, oncology, and more.Read his story

Columbia University Medical Center Division of Hematology/Oncology

161 Fort Washington Ave # Garden

New York, NY 10032
Get Directions

Insurance Accepted

  • Aetna
  • Affinity Insurance Services
  • Amerigroup (Wellpoint)
  • Blue Cross Blue Shield
  • Cigna
  • EmblemHealth
  • Fidelis Care
  • HealthFirst
  • Medicaid
  • Medicare
  • MultiPlan
  • Neighborhood Health Plan
  • Oxford Health Plans
  • UnitedHealthCare

Learn about Dr. Frattini

Be confident in your decisions by checking out your provider's top areas of care, education, patient reviews and more. Learn about finding the right doctor for you.

Top Care Areas

See how frequently Dr. Frattini performs your care needs compared to other doctors.

Myeloproliferative Disorders
very high
more than 97% of peers
Chronic Myeloid Leukemia (CML)
very high
more than 96% of peers
Acute Leukemia
very high
more than 92% of peers

Dr. Frattini's percentages are based on the rate of treatment compared to peers nationwide from insurance data. Learn more info about our data and this Top Care Areas component.

Dr. Frattini's bio

This content was provided by Dr. Frattini "Dr. Mark G. Frattini is an Associate Professor of Medicine and Director of Research for the Hematologic Malignancies Section in the Hematology/Oncology Division at the Columbia University Medical Center. Previously, Dr. Frattini was a member of the Leukemia Service and Experimental Therapeutics Center at Memorial Sloan-Kettering for almost 11 years. He is a medical oncologist who specializes in the treatment of adult patients with acute and chronic leukemias, myelodisplastic syndromes, and myeloproliferative disorders. Dr. Frattini's laboratory research focuses on new drug development for acute and chronic leukemias with a special interest in small molecule inhibitors of cell cycle regulated kinases as therapeutic targets. He has discovered a small molecule inhibitor of the cdc7 kinase that is currently in clinical development with a plan for Phase I clinical studies for patients with relapsed and/or chemotherapy-refractory leukemia in 2013. In addition, Dr. Frattini's research involves the development of methods to more precisely determine patient-specific response to various chemotherapeutic agents with a plan to translate this technology into the clinical setting and provide a more personalized approach to therapy for patients with these malignant diseases. Dr. Frattini has lectured at national and international meetings and has published in various scientific journals, including Blood, Cell, EMBO, JNCCN, Journal of Biological Chemistry, Science, and Proceedings of the National Academy Sciences USA. He received his MD. and PhD in Biochemistry and Molecular Biology from The University of Chicage and completed his fellowship training in medical oncology at The Johns Hopkins Hospital."
Less
Read Less

Care Philosophy

This content was provided by Dr. Frattini "We are committed to delivering the best care and an exceptional patient experience. We are devoted to providing services that are patient-centered and compassionate, and care for you as a person. "

3  Specialties

  • Medical Oncology
  • Internal Medicine
  • Oncology

2  Board Certifications

  • Internal Medicine
    Accredited by: American Board of Internal Medicine*
  • Medical Oncology
    Accredited by: American Board of Internal Medicine*

71  Conditions Treated

  • Acquired Pure Red Cell Aplasia
  • Acute Leukemia
  • Acute Lymphocytic Leukemia
  • Acute Myeloid Leukemia
  • All Lymphoma
  • Anal Disorders
  • Aplastic Anemia
  • Autoimmune Diseases
  • B-Cell Chronic Lymphocytic Leukemia
  • Bleeding Disorders
  • Blood Cancer
  • Blood Disorders
  • Bone Cancer
  • Bone Disorders
  • Brain and Nervous System Cancer (incl. Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
  • Brain Cancer
  • Brain Disorders
  • Breast Cancer
  • Breast Diseases
  • Burkitt's Lymphoma
  • Cancer
  • Central Nervous System Lymphoma
  • Chronic Leukemia
  • Chronic Myeloid Leukemia (CML)
  • Chronic Myelomonocytic Leukemia
  • Esophageal Diseases
  • Essential Thrombocytopenia
  • Gastrointestinal Diseases
  • Gynecologic Cancer
  • Hairy Cell Leukemia
  • Head and Neck Cancer
  • Hemolytic Anemia, Acquired Autoimmune
  • Hemophilia
  • Hemophilia A
  • Hypercoagulable State
  • Immune Thrombocytopenic Purpura (ITP)
  • Lung Cancer
  • Lymphoblastic Lymphoma
  • Lymphoma, Large-Cell
  • Macroglobulinemia (incl. Waldenstrom's )
  • Mantle Cell Lymphoma
  • Marginal Zone Lymphoma
  • Melanoma
  • Meningiomas
  • Multiple Myeloma
  • Mycosis Fungoides
  • Myelodysplastic Syndromes
  • Myelofibrosis
  • Myeloproliferative Disorders
  • Nodular Lymphoma
  • Oral Cancer
  • Ovarian Cancer
  • Peripheral T-Cell Lymphoma
  • Polycythemia Rubra Vera
  • Pregnancy-Related Disorders
  • Primary Central Nervous System Lymphoma
  • Primary Hypercoagulable State (incl. Factor V Leiden Disease)
  • Pulmonary Disease
  • Purpura
  • Reticulosarcoma
  • Retina Diseases
  • Sickle Cell Disease
  • Skin Cancer
  • Small Intestine Cancer
  • Stomach and Small Intestine Cancer
  • Stomach Diseases
  • Thrombocytosis
  • Tongue Cancer
  • Urinary Disorders
  • Vascular Disease
  • von Willebrand Disease
Less
Read Less

4  Procedures

  • Bone Marrow Biopsy
  • Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
  • HPC Transplantation (Stem Cell Transplant)
  • Plasmapheresis

Background Check

0 Malpractice Claims

No malpractice history found for New York.

0 Sanctions

No sanctions history found for the years that Healthgrades collects data.

0 Board Actions

No board actions found for the years that Healthgrades collects data.

Education

  • University Of Chicago/The Pritzker School Of Medicine
    Medical School | Graduated 1997
  • Johns Hopkins Hospital
    Internship Hospital | Completed 1998
  • The Johns Hopkins Hospital
    Residency Hospital | Completed 1999
  • The Johns Hopkins Hospital
    Fellowship Hospital | Completed 2002

Awards & Recognition

Awards & Honors
  • Healthgrades Honor Roll
Media & Publications

Dr. Frattini has no media or publications listed.

Languages Spoken

  • English

Memberships & Professional Affiliations

Dr. Frattini does not have any memberships or affiliations listed. If you are Dr. Frattini and would like to add memberships or affiliations, please update your profile.

Dr. Frattini's Reviews

5.0
Likelihood of recommending Dr. Frattini to family and friends
3 total reviews

Likelihood to Recommend (3)

  • 5
    (3)
  • 4
    (0)
  • 3
    (0)
  • 2
    (0)
  • 1
    (0)

Dr. Frattini's Performance

  • Trustworthiness

    EXCELLENT
  • Explains condition(s) well

    EXCELLENT
  • Answers questions

    EXCELLENT
  • Time well spent

    EXCELLENT

Office & Staff Performance

  • Scheduling

    EXCELLENT
  • Office environment

    EXCELLENT
  • Staff friendliness

    EXCELLENT
  • Average wait time

    10 to 15 minutes
Image of Dr. Frattini
Are you Dr. Frattini?
Make it easy for patients to share their feedback. Also manage your personalized profile!

More Oncology Specialists like Dr. Frattini at Columbia University Medical Center Division of Hematology/Oncology

Hematology Specialist
(8)
Medical Oncology Specialist
(12)
Hematology Specialist
(9)
Medical Oncology Specialist
Medical Oncology Specialist
Hematology Specialist
(2)